Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Qelbree for the treatment of ADHD in pediatric patients

April 6, 2021

Ionis initiates phase III study of ION-363

April 6, 2021

New nitazoxanide derivatives synthesized at Beijing Junke Huayuan Med Tech

April 6, 2021

Seven mostly unknown genes bring order to minimal genome cell division

April 6, 2021

BenevolentAI Bio patents tyrosine-protein kinase ABL1 inhibitors

April 6, 2021

New IRAK-4 inhibitors discovered at Shanghai Institute of Materia Medica

April 6, 2021

Roche identifies new MAGL inhibitors

April 6, 2021

Biotheus describes antibodies targeting carbonic anhydrase IX

April 6, 2021

Positive phase I/II data for VLA-2001 COVID-19 vaccine candidate

April 6, 2021

Initial clinical data from phase I/II SWORD-1 study of TPX-0046

April 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...